Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Study recommends early cystic fibrosis treatment for babies

  • Comment
A study has suggested that treatment for cystic fibrosis should begin with the first six months of a baby’s life.

Researchers in Australia measured forced vital capacity and forced expiratory flows at 75% of exhaled vital capacity on 68 babies with cystic fibrosis and 49 without, aged between six weeks and 30 months.

The infants were assessed 48 hours later for pulmonary infection and inflammation.
Results showed scores did not differ between babies with cystic fibrosis and health controls less than six months of age.

However forced vital capacity score was lower by 1.15 in infants with CF who were older than six months compared with healthy infants.

Authors wrote: ‘Lung function, measured by forced expiration, is normal in infants with CF at the time of diagnosis by newborn screening but is diminished in older infants.

'These findings suggest that in CF the optimal timing of therapeutic interventions aimed at preserving lung function may be within the first 6 months of life.’

American Journal of Respiratory and Critical Care Medicine (2008) 178:1238-1244

See also: The role of the cystic fibrosis nurse specialist

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs